EW vs TERN · P/E 47, rev $1.39B vs $6.12B cap
Edwards Lifesciences Corp (EW) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the EW and TERN stock pages for the full models.
Not investment advice.